Kovack Advisors, Inc. Enzon Pharmaceuticals, Inc. Transaction History

Kovack Advisors, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2015 Oct 29, 2018	SELL	N/A	-16,050 Closed	0 $0
Q2 2015 Nov 06, 2018	BUY	N/A	16,050	16,050 $19,000

Ticker ENZN
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 74,214,600
Market Cap $5.94M
Description
Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Kovack Advisors, Inc. with notifications on news.